JT
LGND icon

Jupiter Topco’s Ligand Pharmaceuticals LGND Stock Holding History

Jupiter Topco’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$329M Buy
+1,040,578
New +$245M 0.13% 156

Other funds holding LGND

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return

Jupiter Topco's LGND Position: Q2 2026 in Review

Jupiter Topco opened a new position in Ligand Pharmaceuticals (LGND) in Q2 2026: 1,040,578 shares worth $329M. The stake represents 0.13% of the portfolio and ranks #156 among its holdings.

392 funds tracked by Wall St. Rank hold LGND as of Q2 2026.

  • Jupiter Topco held 1,040,578 shares of Ligand Pharmaceuticals worth $329M as of Q2 2026.
  • Ligand Pharmaceuticals was a new Jupiter Topco position in Q2 2026.
  • Ligand Pharmaceuticals made up 0.13% of Jupiter Topco's portfolio in Q2 2026, its #156 holding.
  • 392 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.

Based on Jupiter Topco's 13F filing for Q2 2026, filed 14 Aug 2026.